120 related articles for article (PubMed ID: 12488749)
1. Do patients with primary sclerosing cholangitis have a greater frequency of pancreatic abnormalities at MRI than patients with other liver diseases?
Resnick D; Krinsky GA; Lavelle MT; Lee VS; Keogan MT; Morrin MM
J Comput Assist Tomogr; 2002; 26(6):994-9. PubMed ID: 12488749
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic changes in patients with primary sclerosing cholangitis: MR cholangiopancreatography and MRI findings.
Ozkavukcu E; Erden A; Erden I
Eur J Radiol; 2009 Apr; 70(1):118-21. PubMed ID: 18282675
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic changes in primary sclerosing cholangitis: evaluation with MR imaging.
Ito K; Mitchell DG; Outwater EK
AJR Am J Roentgenol; 1999 Dec; 173(6):1535-9. PubMed ID: 10584797
[TBL] [Abstract][Full Text] [Related]
4. Sclerosing cholangitis with autoimmune pancreatitis versus primary sclerosing cholangitis: comparison on endoscopic retrograde cholangiography, MR cholangiography, CT, and MRI.
Kim JH; Byun JH; Kim SY; Lee SS; Kim HJ; Kim MH; Lee MG
Acta Radiol; 2013 Jul; 54(6):601-7. PubMed ID: 23528564
[TBL] [Abstract][Full Text] [Related]
5. Primary sclerosing cholangitis: MR cholangiopancreatography and T2-weighted MR imaging findings.
Düşünceli E; Erden A; Erden I; Karayalçin S
Diagn Interv Radiol; 2005 Dec; 11(4):213-8. PubMed ID: 16320228
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic duct changes are not associated with early signs of chronic pancreatitis at magnetic resonance imaging (MRI) in patients with primary sclerosing cholangitis.
Said K; Albiin N; Lindberg B; Brismar TB; Karrar A; Permert J; Bergquist A
Scand J Gastroenterol; 2010 Aug; 45(7-8):980-6. PubMed ID: 20384530
[TBL] [Abstract][Full Text] [Related]
7. Primary sclerosing cholangitis: MR imaging features.
Ito K; Mitchell DG; Outwater EK; Blasbalg R
AJR Am J Roentgenol; 1999 Jun; 172(6):1527-33. PubMed ID: 10350284
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging features of small-duct primary sclerosing cholangitis.
Kozaka K; Sheedy SP; Eaton JE; Venkatesh SK; Heiken JP
Abdom Radiol (NY); 2020 Aug; 45(8):2388-2399. PubMed ID: 32417935
[TBL] [Abstract][Full Text] [Related]
9. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
Wang C
Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
[TBL] [Abstract][Full Text] [Related]
10. Comparative MRI analysis of morphologic patterns of bile duct disease in IgG4-related systemic disease versus primary sclerosing cholangitis.
Tokala A; Khalili K; Menezes R; Hirschfield G; Jhaveri KS
AJR Am J Roentgenol; 2014 Mar; 202(3):536-43. PubMed ID: 24555589
[TBL] [Abstract][Full Text] [Related]
11. Detection of focal hepatic lesions with MR imaging: prospective comparison of T2-weighted fast spin-echo with and without fat suppression, T2-weighted breath-hold fast spin-echo, and gadolinium chelate-enhanced 3D gradient-recalled imaging.
Soyer P; de Givry SC; Gueye C; Lenormand S; Somveille E; Scherrer A
AJR Am J Roentgenol; 1996 May; 166(5):1115-21. PubMed ID: 8615254
[TBL] [Abstract][Full Text] [Related]
12. Primary sclerosing cholangitis: evaluation with MR cholangiography-a case-control study.
Fulcher AS; Turner MA; Franklin KJ; Shiffman ML; Sterling RK; Luketic VA; Sanyal AJ
Radiology; 2000 Apr; 215(1):71-80. PubMed ID: 10751470
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of imaging criteria for distinguishing autoimmune cholangiopathy from primary sclerosing cholangitis and bile duct malignancy.
Gardner CS; Bashir MR; Marin D; Nelson RC; Choudhury KR; Ho LM
Abdom Imaging; 2015 Oct; 40(8):3052-61. PubMed ID: 26350286
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional magnetic resonance cholangiopancreatography with respiratory triggering in the diagnosis of primary sclerosing cholangitis: comparison with endoscopic retrograde cholangiography.
Textor HJ; Flacke S; Pauleit D; Keller E; Neubrand M; Terjung B; Gieseke J; Scheurlen C; Sauerbruch T; Schild HH
Endoscopy; 2002 Dec; 34(12):984-90. PubMed ID: 12471543
[TBL] [Abstract][Full Text] [Related]
15. Hepatobiliary and coexisting pancreatic duct abnormalities in patients with inflammatory bowel disease.
Heikius B; Niemelä S; Lehtola J; Karttunen T; Lähde S
Scand J Gastroenterol; 1997 Feb; 32(2):153-61. PubMed ID: 9051876
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance cholangiopancreatography in the diagnosis of primary sclerosing cholangitis.
Weber C; Kuhlencordt R; Grotelueschen R; Wedegaertner U; Ang TL; Adam G; Soehendra N; Seitz U
Endoscopy; 2008 Sep; 40(9):739-45. PubMed ID: 18698533
[TBL] [Abstract][Full Text] [Related]
17. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents.
Husarik DB; Gupta RT; Ringe KI; Boll DT; Merkle EM
Acad Radiol; 2011 Dec; 18(12):1549-54. PubMed ID: 21958599
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis.
Berstad AE; Aabakken L; Smith HJ; Aasen S; Boberg KM; Schrumpf E
Clin Gastroenterol Hepatol; 2006 Apr; 4(4):514-20. PubMed ID: 16616358
[TBL] [Abstract][Full Text] [Related]
19. An Imaging Biomarker for Assessing Hepatic Function in Patients With Primary Sclerosing Cholangitis.
Schulze J; Lenzen H; Hinrichs JB; Ringe B; Manns MP; Wacker F; Ringe KI
Clin Gastroenterol Hepatol; 2019 Jan; 17(1):192-199.e3. PubMed ID: 29775791
[TBL] [Abstract][Full Text] [Related]
20. MR imaging of primary sclerosing cholangitis: additional value of diffusion-weighted imaging and ADC measurement.
Kovač JD; Ješić R; Stanisavljević D; Kovač B; Maksimovic R
Acta Radiol; 2013 Apr; 54(3):242-8. PubMed ID: 23386736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
